Reaction

Arterial Thrombosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,918 reports · 51 co-occurring drugs

As of the last recalculation, Arterial Thrombosis appears in 1,918 FAERS reports alongside 51 co-occurring drug terms. The strongest observed disproportionality signal is HEPARIN SODIUM (PRR 25.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Heparin Sodium	32	25.7	25.7
Bleomycin Sulfate	24	25.5	25.6
Basiliximab	18	16.8	16.8
Tafamidis	16	14.9	14.9
Romiplostim	18	13.1	13.1
Cisplatin	88	12.8	12.8
Everolimus Tablets	18	11.8	11.8
Anti-Thymocyte Globulin (Rabbit)	8	10.8	10.8
Ticagrelor	30	10.4	10.4
Melphalan Hydrochloride	23	10.1	10.1
Tranexamic Acid	8	9.8	9.8
Nebivolol	13	8.9	8.9
Alteplase	11	8.0	8.0
Capecitabine	64	7.8	7.8
Eplerenone	9	7.7	7.7
Pemetrexed	15	7.6	7.6
Bevacizumab	79	7.2	7.2
Nilotinib	19	7.1	7.1
Dabigatran Etexilate	48	6.9	6.9
Melphalan	14	6.7	6.7
Etoposide	44	6.6	6.6
Oxaliplatin	44	6.6	6.6
Dabigatran Etexilate Mesylate	43	6.5	6.6
Sorafenib	12	6.3	6.3
Imatinib	10	6.2	6.2
Eltrombopag Olamine	13	6.2	6.2
Norepinephrine	6	6.1	6.1
Thalidomide	20	6.0	6.0
Pemetrexed Disodium	20	5.7	5.7
Fluorouracil Cream, 0.5%	39	5.6	5.6
Fluorouracil	39	5.6	5.6
Fosaprepitant Dimeglumine	7	5.5	5.5
Fondaparinux Sodium	4	5.4	5.4
Prasugrel Hydrochloride	5	5.4	5.4
Drospirenone And Ethinyl Estradiol	21	5.2	5.2
Testosterone Cypionate	4	4.9	4.9
Bosutinib	4	4.8	4.8
Rivaroxaban	89	4.8	4.8
Carboplatin	54	4.7	4.7
Paclitaxel (Aibumin-Bound)	34	4.6	4.6
Cetuximab	13	4.5	4.5
Erlotinib	4	4.5	4.5
Gemcitabine	16	4.4	4.4
Encorafenib	4	4.4	4.4
Erlotinib Hydrochloride	5	4.3	4.3
Gemcitabine Hydrochloride	21	4.3	4.3
Paclitaxel	37	4.1	4.1
Atezolizumab	14	3.9	3.9
Sofosbuvir	5	2.8	2.8
Emicizumab	3	2.6	2.6
Remdesivir	3	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.